[Liebert] Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma

kleinhev Post time 2024-5-23 17:41:33 | Show all posts |Read mode
Reward30points

Edited by kleinhev at 2024-5-23 17:42

journal:Thyroid(R)

Authors:Sarah Hamidi; Priyanka C. Iyer; Ramona Dadu; Maria K. Gule-Monroe; Anastasios Maniakas; Mark E. Zafereo; Jennifer R. Wang; Naifa L. Busaidy; Maria E. Cabanillas

Published date:2024-3-1

DOI:10.1089/thy.2023.0573

PDF link:https://www.liebertpub.com/doi/full-xml/10.1089/thy.2023.0573

Article link:http://dx.doi.org/10.1089/thy.2023.0573

Article Source:Mary Ann Liebert Inc


Remark:

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
fernandoribeiro Post time 2024-5-23 17:41:34 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    775

Latest Reply

Return to the list